Metabolic Health
More than 155 million Americans are either living with diabetes or on their way to it right now. Most of them do not know it. And the ones who do are often told to…
More than 155 million Americans are either living with diabetes or on their way to it right now. Most of them do not know it. And the ones who do are often told to “watch what they eat and come back in six months” — without any real plan to stop the financial and physical cost that is already building.
This article is about the money. Not to scare you, but to show you something important: the earlier you intervene, the smaller the bill. And the window to act at the cheapest point does not stay open forever.
Diabetes is now one of the most expensive chronic conditions an American can develop. The good news is that the most costly stages are also the most preventable — if you catch the warning signs early enough.
These numbers come from the CDC's National Diabetes Statistics Report, published in January 2026, based on 2023 data.
Pre-diabetes is not a safe place to stay. Without meaningful intervention, the path toward type 2 diabetes is well-documented — and moves faster than most people expect.
That last bar is the most important one. Up to 70 percent of people with pre-diabetes will develop type 2 diabetes if they do nothing. But a structured program targeting modest weight loss and increased movement reduces that risk by 58 percent — and by 71 percent in adults over 60. The biology is not fixed. The outcome is not set. The question is whether you know where you stand early enough to do something about it.
Sources: ADA; CDC National Diabetes Prevention Program; Lancet / PMC3891203; US Pharmacist 2022
These figures reflect estimated annual out-of-pocket costs for insured American adults.
3 Year Shock: What crossing the diagnosis line costs in the short term
The financial jump at diagnosis is not gradual. Research tracking commercially insured adults found that the moment a pre-diabetes case becomes a type 2 diabetes case, spending accelerates sharply.
GLP-1 medications like Ozempic or Mounjaro are not even on that list yet. Without insurance coverage, those medications run $800 to $1,000 per month. One in four health care dollars spent in the United States now goes toward diabetes care.
The $375 Advanced Functional Health Assessment is designed to find where you are on this spectrum before the costs — and the damage — escalate. For someone in their 40s or 50s, that single investment could prevent thousands of dollars in recurring expenses every year for the rest of their life. We look at fasting insulin, HOMA-IR, and a full metabolic panel to catch insulin resistance years before it shows up on a standard A1C test.
Not sure where you stand metabolically? That is exactly what we are here to figure out together.
Schedule Your Free Discovery Call
This article was originally published on the 4Core Substack.
